Sangeeta Mudnal, Principal Group Program Manager, Responsible AI, Microsoft
Abstract:
Microsoft Research is contributing our Artificial Intelligence and Machine Learning expertise towards important research questions at the intersection of cancer and the immune system. Cancer is the second leading cause of death in the United States. Many of us have a friend or loved one who has battled cancer, motivating us to contribute our research talents to improve cancer treatment. Recently, immunotherapies – drug advancements that work to harness the immune system to fight cancer – are producing complex, high-dimensional datasets that can benefit from interdisciplinary attention, including from computer scientists.
Science has called cancer immunotherapy a revolution due to encouraging clinical responses from the rapid pace of drug development and FDA approvals. We are working on this important topic in partnership with cancer researchers around the country.
In this talk, we will cover the basic understanding of when and why immunotherapies are most likely to work. Ultimately, our goal is to help medical practitioners figure out how to most effectively target cancer immunotherapies using AI and ML.
Add comment